Turnaround the performance and make a big profit of 5 billion yuan! 220 institutions quickly investigated!

Securities Times E Company

2024-05-12 08:34Published on the official account of "Company E" under Guangdong Securities Times

This week (May 6-10), the A-share market fluctuated upward, and the Shanghai Composite Index hit a new high this year. The Shanghai Composite Index rose 1.60% for the week to close at 3,154.55 points. The Shenzhen Component Index and ChiNext Index rose 1.50% and 1.06% respectively for the week.

In terms of industry performance, from the perspective of Shenwan's primary industry, public utilities, agriculture, forestry, animal husbandry and fishery, and non-ferrous metal industries rose first this week, while the computer, communications, and media industries, which rose strongly in the first two weeks, performed weakly this week.

On the hot concept, artificial meat, shipping, hydropower, commercial aerospace and other concepts are active this week, and the shipping sector has risen significantly, mainly because the shipping industry has gradually increased its price in May, and the expectation of rising freight rates is still strong, and the price increase is expected to increase sharply in June.

In addition, in the second half of the week, the real estate sector also rose by about 5% in the context of the relaxation of real estate policies.

This week, the sentiment of institutional research has cooled slightly compared with before the "May Day" holiday, although the number of individual stocks surveyed by institutions has increased, but the number of individual stocks surveyed by institutions has declined sharply.

Wind data shows that as of May 10, a total of 217 A-share listed companies were surveyed by institutional investors during the week, a significant increase from the pre-holiday data. Among them, 14 companies, including Baili Tianheng-U, Tianyue Advanced, Focus Media, Xu Ji Electric, and Qianjiang Motorcycle, were surveyed by more than 100 institutions, which was lower than the pre-holiday data.

The target with the largest number of research institutions is Baili Tianheng-U, which has been surveyed by a total of 220 institutions this week.

It is worth mentioning that Baili Tianheng-U has risen by more than 25% this week, and the stock price has hit a record high, as of the close of May 10, Baili Tianheng-U rose 6.06%, with a closing price of 194.11 yuan, and the closing price hit a record high. Since the end of April, the company's share price has risen by 55%, and its latest market value has increased to 77.8 billion yuan.

In terms of performance, Baili Tianheng achieved a net profit of 5.005 billion yuan in the first quarter by virtue of a down payment of 800 million US dollars with Bristol-Myers Squibb (BMS), ending three consecutive years of losses and turning losses into profits.

In addition, the progress of Baili Tianheng's innovative drugs has also attracted considerable attention. The company recently announced that "BL-B01D1+PD-1 monoclonal antibody ± chemotherapy" for the treatment of a variety of advanced solid tumors has obtained 7 phase II clinical trial approval notices, and the innovative drug has been included in the NMPA breakthrough therapy drug varieties. The advancement of this innovative drug trial may bring new treatment options to patients with a variety of advanced solid tumors.

Baili Tianheng's main business is the research and development, production and sales of drugs, and its main products include Haohao Astragalus (Astragalus granules), Xinbo Chai Huang (Chai Huang granules), Dura Bao (racemic caddotril granules), Xinbolin (ribavirin granules), Oberlin (ornidazole capsules), Leweijing (propofol injection), Paisin (pazhufloxacin mesylate for injection), etc.

In the process of research, institutional investors focused on the treatment of BL-B01D1 (EGFR×HER3-ADC) in the field of non-small cell lung cancer, and whether it will be combined with PD-(L)1 to carry out first-line or even neoadjuvant phase III in the future.

Baili Tianheng responded that the phase II clinical study of BL-B01D1 combined with PD-1 monoclonal antibody has obtained the "Drug Clinical Trial Approval Notice" in 8 indications, of which the phase II clinical study of the combination of non-small cell lung cancer in the first line has been initiated.

Subsequently, the company will design a plan for the phase III registration study based on the clinical efficacy performance and safety data seen in phase II, and will consider advancing the combined clinical study to a more front-line stage such as neoadjuvant therapy in the future.

This week, the company that the institutions focused on researching also included Focus Media, a star company that the market has paid attention to, with a total of 170 institutions surveying the company during the week. During the survey, institutional investors asked Focus Media questions about the structure and future trends of the advertiser industry, and the impact of the development of AI technology on the company and the overall ladder media industry.

Regarding the changes in the structure of the advertiser industry, Focus Media said that in 2023, the performance of consumer goods customers in building media will still be outstanding, and the proportion will increase year by year since 2017, from 19.76% in 2017 to 52.80% in 2023, of which the number of new energy vehicles and the unit price of customers have increased compared with the same period last year, and the communication industry has increased by 178.57% year-on-year, mainly due to the advertising of AI application hardware devices.

Focusing on the impact of AI technology on the company and the industry, Focus Media said that AI technology will revolutionize the advertising media industry, and the company's marketing vertical model has been deployed and is continuing to fine-tune and iterate. Focus Media's large model is mainly applied to three dimensions, including content generation, content feedback optimization, and delivery method optimization.

Founded in 2003, Focus Media created an elevator media advertising model, became the first Chinese advertising media stock to be listed on the NASDAQ in 2005, and was included in the NASDAQ 100 index in 2007. In 2015, Focus Media returned to A-shares, with a market value of more than 100 billion yuan, becoming the first media stock in China. As of the close of trading on May 10, Focus Media's latest market value was 95.6 billion yuan.

It is worth mentioning that, thanks to the release of travel demand during the "May Day" holiday, SSAW Hotel has also attracted the attention of 85 institutional investors, and institutions are generally concerned about the hotel's operation and hotel market characteristics during the "May Day" period.

SSAW Hotel said that due to the year-on-year increase in average room rate brought about by the entry of high-quality newly opened hotels into the market, the revenue of SSAW Boutique Hotel's directly operated stores during the "May Day" period was close to 9 million yuan, an increase of 20% year-on-year, and RevPAR (revenue per room) increased by 15% year-on-year in 2019, which basically remained stable compared with last year.

SSAW Boutique Hotel also pointed out that the performance of leisure and vacation hotels during this year's "May Day" holiday is particularly prominent, with the following three characteristics:

First, the peak occurred in the first three days, during which both OCC (occupancy rate) and ADR (average house price) peaked, and fell significantly in the second two days after the holiday;

Second, in terms of regional distribution, the operation of second- and third-tier cities is better than that of first-tier cities, the performance of county-level cities is eye-catching, and the core business districts of first-tier cities are still hot, while the performance of the Hainan market is relatively weak;

Third, hotels around the city that have both business functions and leisure elements are more popular with tourists, such as Yangzhou, Jiangsu, Tonglu, Zhejiang and Lishui, Zhejiang, etc., and the proportion of parent-child travel is relatively high.

Founded in 2007, SSAW Hotel is a listed company on the Growth Enterprise Market of the Shenzhen Stock Exchange, focusing on the accommodation business for 25 years, and is also a high-end business hotel and resort hotel operator in China, as well as a pioneer of mid-to-high-end clean hotels and lifestyle hotels, headquartered in Hangzhou, China.

For the differentiation of leisure demand and business demand in the hotel industry, SSAW Boutique Hotel also said in the survey that it has entered the era of mass consumption, and the traditional popular tourist cities and scenic spots are still popular with tourists, while some second- and third-tier cities and county cities have also become new hot spots, and the market has expanded to show a diversified consumption trend, which provides more opportunities for high-end hotels to think. In order to cope with market changes, mid-to-high-end hotels need to create richer experience designs and better products to expand the hotel's experience space and enrich the product experience.

View original image 190K

• 

•